Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Mathian

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
Annals of the Rheumatic Diseases|October 2, 2020
Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'Florence Jeny, Raphael Lhote, Gwenael Lorillon, et al.
Annals of the Rheumatic Diseases|March 15, 2018
Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre studyGuillaume Moulis, Grégory Pugnet, Nathalie Costedoat-Chalumeau, et al.
Autoimmunity Reviews|May 10, 2017
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patientsPierre-Edouard Gavand, Ilaria Serio, Laurent Arnaud, et al.
Journal of Autoimmunity|June 30, 2019
CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admissionMarc Pineton de Chambrun, Romaric Larcher, Frédéric Pène, et al.
Chest|November 30, 2019
In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU AdmissionMarc Pineton de Chambrun, Romaric Larcher, Frédéric Pène, et al.
Journal of the American Society of Nephrology : JASN|May 7, 2025
Histologic Features Associated with Kidney Survival in Scleroderma Renal CrisisYannick Binois, David Buob, Marie-Sophie Meuleman, et al.
Plos One|September 16, 2017
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsMikael Ebbo, Aurélie Grados, Maxime Samson, et al.
Rheumatology (Oxford, England)|July 1, 2026
Development and validation of a Relapsing Polychondritis disease-specific Quality of Life instrument (ERN ReCONNET RP-QoL)Laurent Arnaud, Oliver Sander, Laura Damian, et al.
Autoimmunity Reviews|July 10, 2012
The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritisLaurent Arnaud, Hervé Devilliers, Stanford L Peng, et al.
Journal of Internal Medicine|April 4, 2022
Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort studyClémence David, Nathalie Costedoat-Chalumeau, Drifa Belhadi, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Annals of the Rheumatic Diseases|October 2, 2020
Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'Florence Jeny, Raphael Lhote, Gwenael Lorillon, et al.
Annals of the Rheumatic Diseases|March 15, 2018
Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre studyGuillaume Moulis, Grégory Pugnet, Nathalie Costedoat-Chalumeau, et al.
Autoimmunity Reviews|May 10, 2017
Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patientsPierre-Edouard Gavand, Ilaria Serio, Laurent Arnaud, et al.
Journal of Autoimmunity|June 30, 2019
CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admissionMarc Pineton de Chambrun, Romaric Larcher, Frédéric Pène, et al.
Chest|November 30, 2019
In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU AdmissionMarc Pineton de Chambrun, Romaric Larcher, Frédéric Pène, et al.
Journal of the American Society of Nephrology : JASN|May 7, 2025
Histologic Features Associated with Kidney Survival in Scleroderma Renal CrisisYannick Binois, David Buob, Marie-Sophie Meuleman, et al.
Plos One|September 16, 2017
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patientsMikael Ebbo, Aurélie Grados, Maxime Samson, et al.
Rheumatology (Oxford, England)|July 1, 2026
Development and validation of a Relapsing Polychondritis disease-specific Quality of Life instrument (ERN ReCONNET RP-QoL)Laurent Arnaud, Oliver Sander, Laura Damian, et al.
Autoimmunity Reviews|July 10, 2012
The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritisLaurent Arnaud, Hervé Devilliers, Stanford L Peng, et al.
Journal of Internal Medicine|April 4, 2022
Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort studyClémence David, Nathalie Costedoat-Chalumeau, Drifa Belhadi, et al.
Pageof 22